close-bbt

news fly out

×HOMEBlack HistoryBusiness & FinanceEducationEntertainmentFaith & FamilyFood & TravelHBCUHealthNewsLove & RelationshipsOther NewsTechnology
Home

  • Business
  • Entertainment
  • Food & Travel
  • Health
  • News
  • Politics
  • Technology
  • Publishers

Health

Drug Cut Genetic Cholesterol 78%, But Heart Risks Didn’t Fall

14h

**An experimental drug that sharply lowered levels of an inherited form of cholesterol failed to protect patients from heart attacks and strokes, leaving researchers searching for answers. Novartis’ pelacarsen reduced lipoprotein(a), or Lp(a), by 78% in the Phase 3 Horizon trial. The study included 8,322 people with elevated Lp(a) and a history of heart attack, …

The postDrug Cut Genetic Cholesterol 78%, But Heart Risks Didn’t Fallappeared first onEURweb | Black News, Culture, Entertainment & More.

You May Also Like


Trending Topics

Install the app today!

ap_store.pngApp

Get in touch with us

Reach out to the Hayti team about
collaborating or working together.

CONTACTinfo@hayti.com
hayti_logo.png
Company
  • Press & Media
  • Contact Us
Partners
  • Publishers
  • Podcasters
Terms and Policies
  • Terms for Publishers
  • Terms for Podcasters
Stay Connected
  • BOMESI-badge_WH1.png

© 2026 Hayti LLC. All rights reserved.

  • Privacy Policy.
  • Terms of Use.